Abstract
Stereoselective disposition of sulbenicillin (SBPC) epimers in healthy human volunteers was studied in order to clarify the differences in pharmacokinetic behavior between the epimers. Stereospecific high-performance liquid chromatography was used for the determination of SBPC epimers. Plasma protein binding was measured in vitro with an ultrafiltration method. The binding was stereoselective, with the unbound fraction (fu) of the R-epimer being approximately 1.3-fold greater than that of the S-epimer. SBPC was administered intravenously to human volunteers, and concentrations of SBPC in plasma and urinary excretion rates were measured. Renal clearance (CLR) for the unbound drug (approximately 400 ml/min) was greater than the glomerular filtration rate (GFR) (approximately 109 ml/min) for both epimers, suggesting that both epimers are secreted at the renal tubules. Renal tubular secretion appeared to be greater for the S-epimer. When probenecid was coadministered, the CLR values of both epimers were significantly reduced and were approximately equal to the GFR values. CLR was greater for the S-epimer (37.5 and 49.8 ml/min for R-SBPC and S-SBPC, respectively), which was simply due to the greater fu of the S-epimer in plasma. In ...Continue Reading
References
Jan 11, 1979·Journal of Chromatography·K YamaokaT Uno
Mar 1, 1975·Clinical Pharmacology and Therapeutics·I B HansenJ Weis
Mar 1, 1992·European Journal of Biochemistry·W KramerW Schiebler
Jan 1, 1990·Chemical & Pharmaceutical Bulletin·Y AsoY Takeda
Apr 1, 1989·Pharmaceutical Research·T YoshikawaH Yamada
Apr 1, 1989·Pharmaceutical Research·N MuranushiH Yamada
May 1, 1988·The Journal of Pharmacy and Pharmacology·I TamaiA Tsuji
Jan 1, 1985·Journal of Pharmaceutical Sciences·N Hashimoto, H Tanaka
Aug 1, 1971·Journal of Pharmaceutical Sciences·K B BischoffJ A Longstreth
Jul 17, 1965·Nature·B K Martin
Sep 1, 1984·Chemical & Pharmaceutical Bulletin·T Fujita, A Koshiro
Nov 1, 1983·Journal of Pharmaceutical Sciences·A TsujiT Yamana
Mar 1, 1984·Journal of Pharmaceutical Sciences·N HashimotoH Tanaka
Jan 1, 1981·Journal of Pharmaceutical Sciences·H YamadaH Kinoshita
Nov 1, 1981·Journal of Pharmacobio-dynamics·K YamaokaT Uno
Mar 3, 1995·Journal of Chromatography. a·T Itoh, H Yamada
Jan 14, 1994·Journal of Chromatography·M IshidaH Yamada
Nov 1, 1993·Antimicrobial Agents and Chemotherapy·T ItohH Yamada
May 1, 1993·Journal of Pharmaceutical Sciences·J ShimadaH Yamada
Jan 1, 1996·Chirality·T ItohH Yamada
Citations
Apr 24, 2001·Chirality·Y TsudaT Itoh
Nov 17, 2007·Fundamental & Clinical Pharmacology·M Strolin BenedettiM Canning
Feb 23, 2021·ACS Pharmacology & Translational Science·Mayra Quemé-PeñaTamás Beke-Somfai
Feb 18, 2017·Clinical Pharmacokinetics·Anton IvanyukThierry Buclin
Jan 24, 2004·The Journal of Pharmacy and Pharmacology·D M KarpfR W Milne
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·Meng LiJoanne Wang